Similar quit rates are found with three smoking cessation options

The drug varenicline (Champix) was found to be no better than combination nicotine replacement therapy or a standard nicotine patch in helping adults to stop smoking in the long term, a randomised controlled trial published in JAMA has shown.1

The researchers said that their open label study was the first to contrast varenicline and combination nicotine replacement therapies directly, both with one another and with the nicotine patch. Such a comparison …